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REELIN (RELN) is a large (420 kDa) glycoprotein that in adulthood is mostly synthesized
in GABAergic neurons of corticolimbic structures. Upon secretion in the extracellular
matrix (ECM), RELN binds to VLDL, APOE2, and α3β2 Integrin receptors located on
dendritic shafts and spines of postsynaptic pyramidal neurons. Reduced levels of RELN
expression in the adult brain induce cognitive impairment and dendritic spine density
deficits. RELN supplementation recovers these deficits suggesting a trophic action for
RELN in synaptic plasticity. We and others have shown that altered RELN expression in
schizophrenia (SZ) and bipolar (BP) disorder patients is difficult to reconcile with classical
Mendelian genetic disorders and it is instead plausible to associate these disorders
with altered epigenetic homeostasis. Support for the contribution of altered epigenetic
mechanisms in the down-regulation of RELN expression in corticolimbic structures
of psychotic patients includes the concomitant increase of DNA-methyltransferases
and the increased levels of the methyl donor S-adenosylmethionine (SAM). It is
hypothesized that these conditions lead to RELN promoter hypermethylation and a
reduction in RELN protein amounts in psychotic patients. The decreased synthesis
and release of RELN from GABAergic corticolimbic neurons could serve as a model
to elucidate the epigenetic pathophysiological mechanisms acting at pyramidal neuron
dendrites that regulate synaptic plasticity and cognition in psychotic and non-psychotic
subjects.
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INTRODUCTION
REELIN (RELN) is an extracellular matrix (ECM) glycoprotein that controls neuronal cell
migration and the lamination of the corticolimbic structures during embryonic development
(D’Arcangelo et al., 1995). RELN also plays a role in controlling dendritic spines, and
synapse structure and function in adulthood (Costa et al., 2001). Research in the last 20
years, has suggested that abnormal brain RELN expression is a feature that associates
with major neuropsychiatric disorders including schizophrenia (SZ), bipolar (BP) disorder
(Impagnatiello et al., 1998; Fatemi et al., 2000; Guidotti et al., 2000), autism (Fatemi, 2002),
depression (Lussier et al., 2009, 2011, 2013), and Alzheimer’s disease (Herz and Chen,
2006). While the role of RELN in dendritic spine structure, synapse plasticity, and cognitive
function in adulthood has been extensively studied, considerably less research has focused
on the mechanisms whereby RELN expression is altered in neuropsychiatric conditions.
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FIGURE 1 | Photomicrographs of 20 µm sections of prefrontal cortex (PFC) of a non-psychiatric subject (NPS) and of a schizophrenia patient (SZP)
immunolabeled for RELN (A,C, left side) or Nissl-stained (B,D, right side). RELN positive neurons are mostly localized in layer 1. Note that the NPS has a
higher density of RELN-positive cells and also a stronger extracellular diffuse RELN immunostaining halo. Reprinted with permission from Guidotti et al. (2000).
Here, we review evidence for a role of the epigenetic control of the
expression of RELN in the regulation of neuronal plasticity and
behavior in SZ and BP disorder patients compared with controls
devoid of major psychiatric disorders.
RELN IN THE ADULT MAMMALIAN BRAIN
Neuronal Location
In the cortex and hippocampus of adult rodents and primates,
RELN is predominantly synthesized and secreted by GABAergic
interneurons (Alcántara et al., 1998; Impagnatiello et al., 1998;
Pesold et al., 1998, 1999; Guidotti et al., 2000; Rodriguez et al.,
2000; Kadriu et al., 2012). Immunohistochemistry coupled to
in situ hybridization studies distinguishes at least two sets of
GABAergic interneurons based on their ability to synthesize
and secrete RELN. The first synthesizes and secretes RELN
onto apical and basal dendrites of pyramidal neurons and
includes GABAergic horizontal, double bouquet, multipolar
and Martinotti neurons in layers 1 and 2 of the mammalian
cortices (Figure 1). The second set of GABAergic neurons, which
do not usually express RELN, include chandelier and basket
interneurons that innervate the axon initial segment or somata
of pyramidal neurons, respectively (Pesold et al., 1998, 1999). In
contrast, in cerebellum, RELN is predominately synthesized by
glutamatergic granule neurons, and is secreted by their parallel
fiber axon terminals into the ECM surrounding the dendrites
of GABAergic Purkinje cells (Pesold et al., 1998). Studies in
primary cultures of rat cerebellar granule cells suggest that
RELN is secreted in the extracellular medium in a manner
that is blocked by the constitutive secretory pathway inhibitor
brefeldin. Moreover, secretion of RELN is independent of
neuronal activity (Lacor et al., 2000). These findings suggest
the possibility that secretory pathway activators might be
useful in facilitating RELN secretion when RELN expression is
compromised.
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Extracellular Location
Once released in the extracellular space, RELN binds to
VLDL, APOE and α3β1 integrin receptors activating the signal
transduction system in the effector cells including apical and
basilar dendrites of pyramidal neurons in the neocortex or
Purkinje cells in the cerebellum (D’Arcangelo et al., 1999;
Hiesberger et al., 1999; Dong et al., 2003; Strasser et al.,
2004).
Using electron microscopic techniques, Costa et al. (2001)
demonstrated the presence of RELN-like immunoreactivity
decorating the dendritic shafts and spines of distal apical
dendrites of pyramidal neurons in the frontal cortex. This
area, as well as the hippocampal fissure, is characterized by
strong diffuse RELN–immunoreactivity (Pesold et al., 1998).
The colocalization of RELN with the α3 subunit of the integrin
receptor at post-synaptic densities of adult rat and primate
brains suggests that a RELN signaling mechanism involving
integrin and VLDL and APOE2 receptors may be operative
in modulating the strength of synaptic function (Rodriguez
et al., 2000; Dong et al., 2003; Niu et al., 2004). It has
been shown that RELN interacting with VLDL, APOE2, or
integrin receptors results in activation of the Src-tyrosine
kinase family Fyn-kinase, leading to tyrosine phosphorylation
and recruitment of the cytoplasmic adaptor protein DAB1
(Figure 2; Jossin et al., 2003; Bock et al., 2004; Kuo
et al., 2005). Studies suggest that DAB1 phosphorylation is
a crucial step in the activation of RELN signal transduction
pathways (Rice et al., 1998; Trommsdorff et al., 1999; Niu
et al., 2004; Howell and Pillai, 2015). DAB1 is frequently
expressed in proximity of synapses located on dendritic spines
or shafts of cortical pyramidal neurons (Rodriguez et al.,
2000). Hence, phosphorylated DAB1 may regulate cytoskeletal
protein synthesis at dendrites by activating the translation of
dendritic resident mRNAs (see Figure 2, from Costa et al.,
2001).
RELN REGULATES SPINE DENSITY AND
EXCITATORY SYNAPTIC FUNCTION
Animal models in which RELN expression is genetically reduced
provide important information on the impact of RELN on
synaptic plasticity and cognition. Reeler mice display altered
LTP and deficits in active avoidance tasks (Goldowitz and Koch,
1986; Marrone et al., 2006). Young adult heterozygous reeler
mice (HRM) which exhibit a 50% reduction in RELN content
have significantly reduced dendritic spine densities and also
show a deficit in LTP (Tueting et al., 1999, 2006; Liu et al.,
2001; Levenson et al., 2008; Niu et al., 2008; Iafrati et al., 2014).
Adult HRM also have a defective molecular composition of
the synaptic structure (Ventruti et al., 2011), as well as deficits
in excitatory postsynaptic responses to glutamate receptor
agonists and reduced LTP (Levenson et al., 2006). Addition of
recombinant RELN to hippocampal slices or direct injection
of RELN into the cerebral ventricles enhances hippocampal
LTP (Beffert et al., 2006; Pujadas et al., 2010; Rogers et al.,
2011).
FIGURE 2 | Schematic representation of the RELN signaling pathways
in dendritic spines. RELN released in the extracellular matrix (ECM) from the
terminal of cortical GABAergic neuron binds to dendritic shafts and spines and
modulates the transcriptional function of activated dendritic synapses.
Modified from Costa et al. (2001). RELN binding to Integrin receptors located
on dendritic spines mediates activation of focal adhesion kinase (FAK) that
directly or indirectly, via activation of Fyn kinase, phosphorylates DAB1 adaptor
protein resident in dendrites. Phosphorylated dendritic DAB1 may recruit or
activate ribosomal structures and induce the synthesis of ARC (Activity
regulated cytoskeletal-associated protein) or cytoskeletal proteins like β-actin.
HRM also display deficits in cognitive function
(Krueger et al., 2006; Stranahan et al., 2011), executive
function (Brigman et al., 2006), fear conditioning learning
(Ammassari-Teule et al., 2009), anxiety and motor impulsivity
(Ognibene et al., 2007). Importantly, RELN supplementation
recovers sensory motor gating, synaptic plasticity, and
associative learning deficits in HRM (Rogers et al., 2013).
In addition to the HRM data described above, Lussier et al.
(2013) reported that hippocampal RELN deficiency elicited
by chronic stress (repeated corticosterone treatment) can
impair adult hippocampal neurogenesis and lead to the
development of a depression-like phenotype. Co-treatment
with antidepressant drugs prevents both RELN deficit and the
development of the depression-like phenotype (Fenton et al.,
2015).
Addition of recombinant RELN to cortical synaptosomes
in vitro induces the expression of activity-regulated
cytoskeleton-associated protein (Arc; Dong et al., 2003),
and augments the density and clustering of proteins
in postsynaptic membranes (i.e., neurotransmitter
receptors), which provides further evidence of a functional
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role for RELN in regulating the synaptic strength of
glutamatergic inputs onto dendritic spines (Caruncho et al.,
2004).
RELN IN THE BRAINS OF
SCHIZOPHRENIA (SZ) AND BIPOLAR (BP)
DISORDER PATIENTS
A number of molecular, anatomical (dendritic spine density),
behavioral, and cognitive deficits associated with reduced
RELN expression (mRNA and protein) are observed in
subjects with SZ and BP disorder. In different post-mortem
brain cohorts, we and others have demonstrated that
RELN expression is reduced by approximately 50% in the
prefrontal cortex (PFC), temporal cortex, hippocampus,
and caudate nucleus of patients with SZ and BP disorder
(Impagnatiello et al., 1998; Fatemi et al., 2000; Guidotti et al.,
2000). In successive studies we found that the expression of
RELN was paralleled by decreases in the levels of GAD67
but not DAB1 or GAD65. Slices from the same samples
immunostained for RELN and counterstained for Nissl or
NeuN to recognize neurons showed that RELN-positive
neurons were significantly decreased by 30–50% in patients
with SZ or BP disorder with psychosis but not in those
with unipolar depression when compared to non-psychiatric
subject (NPSs; Figure 1). Differences were absent for GAD65,
and NeuN expression implying that RELN and GAD67
down-regulation is unrelated to neuronal damage (Guidotti
et al., 2000). The RELN and GAD67 downregulation is
also unrelated to postmortem interval, dose, duration, or
presence of antipsychotic medication. Similar to HRM, RELN
deficiency in the neocortex of SZ and BP disorder patients
is associated with a decrease in GAD67, reduced prepulse
inhibition to startle, and loss of dendritic spines, all features
associated with SZ pathology (Tueting et al., 1999; Glantz
and Lewis, 2001; Liu et al., 2001; Grayson and Guidotti,
2013).
Like the RELN deficiency in the cerebellar cortex of
HRM, the RELN deficiency in cerebellar cortex of SZ and
BP disorder patients is associated with a 20% decrease of
GABAergic Purkinje neurons (Hadj-Sahraoui et al., 1996;
Maloku et al., 2010). Collectively these data suggest that
RELN plays a central role in inducing and maintaining
the structure and function of GABAergic and glutamatergic
neurons and their reciprocal interactions (Grayson and Guidotti,
2013).
Since SZ and BP disorder have a neurodevelopmental
origin (Folsom and Fatemi, 2013) and RELN is a major
player in brain development and maturation (D’Arcangelo
et al., 1995), an important question raised by these studies is
whether the altered epigenetic (promoter hypermethylation)
regulation of RELN in brains of SZ and BP patients is initiated
early in embryonic or perinatal life or develops later in
life as the consequence of the GABAergic neuropathology
related to the development of SZ morbidity. To address
this question, the extent of methylation of the RELN
promoter was measured in offspring born from mice stressed
during pregnancy. These offspring, at adulthood, display
SZ-like behavioral endophenotypes (increased locomotor
activity, PPI, social recognition deficits), and a decrease
of RELN, GAD67, and BDNF expression associated with
an increase in methylation at their respective promoters.
We also found that the amount of Methyl CpG Binding
Protein 2 (MECP2) binding to the RELN promoter at birth
was higher than that observed in the adult (Matrisciano
et al., 2013). These data suggest that RELN promoter
hypermethylation is likely initiated early in life, including
during embryonic life, and is then maintained throughout
adulthood.
IS AN ALTERED EPIGENETIC
REGULATION OF GENE EXPRESSION THE
MOLECULAR MECHANISM MEDIATING
RELN EXPRESSION DOWN-REGULATION
IN SZ AND BP DISORDER?
Mutations in the RELN gene are associated with a form
of autosomal recessive lissencephaly with abnormal axonal
connectivity, and cerebellar hypoplasia (Hong et al., 2000).
Human subjects with RELN gene mutations exhibit marked
ventricular dilation, mental retardation, and epilepsy and a
marked decrease in muscle tone that appears of neurogenic
origin (Hourihane et al., 1993). Heterozygous RELN mutations
have been shown to cause autosomal-dominant lateral temporal
epilepsy (Dazzo et al., 2015).
A highly conserved single nucleotide polymorphism (SNP)
has been identified in the vicinity of the regulatory region of the
RELN gene (Shifman et al., 2008; Wedenoja et al., 2010). This
polymorphism is associated with an increased risk of psychotic
symptoms. Although these studies highlight the importance
of RELN gene variants as risk factors in the etiopathogenesis
of psychiatric disorders, it is important to note that variants
in the RELN gene are rare and cannot explain the high
frequency of RELN expression downregulation observed in the
general population of SZ, BP disorder and autism spectrum
disorder patients (Zhang et al., 2002; Lintas and Persico, 2010;
Grayson and Guidotti, 2013; Wang et al., 2014; Zhubi et al.,
2014).
The epidemiological and clinical evidence that SZ and BP
disorders do not follow the rules expected for a Mendelian-
genetic disorder led to the proposal that environmental
insults may influence RELN gene expression by altering
epigenetic regulatory mechanisms and led to the hypothesis
that epigenetic factors are operative in mediating changes
in the expression of RELN and other SZ candidate genes in
psychotic patients (Costa et al., 2003). To better understand
the rules governing the epigenetic regulation of RELN, we
cloned the human gene and experimentally examined its
regulation in both neuroprogenitor NT2 cells (Chen et al.,
2002; Mitchell et al., 2005) and mouse cortical neurons in
vitro (Dong et al., 2003; Noh et al., 2005). Data from these
studies support the concept that the RELN promoter is
regulated epigenetically through changes in DNA methylation.
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Furthermore, we have reported that the down-regulation
of RELN expression in GABAergic neurons of SZ and
BP patients is associated with an overexpression of DNA
methyltransferase 1 (DNMT1) and DNA methyltransferase
3a (DNMT3a) in neocortical and striatal GABAergic neurons
(Veldic et al., 2004, 2007; Ruzicka et al., 2007). DNMTs
are a family of enzymes that catalyze the transfer of a
methyl group from the methyl donor S-adenosylmethionine
(SAM) to the 5′ carbon of cytosine of many gene promoters
(Grayson and Guidotti, 2013). Increased promoter methylation
generally leads to decreased gene expression. Interestingly,
the inhibitory action of DNMTs on RELN expression also
likely occur through the formation of chromatin repressor
complexes which include, in addition of DNMTs, also
the methyl CpG binding domain proteins, SIN3A, and
histone deacetylases (see Grayson and Guidotti, 2013 for
review).
The hypothesis that an epigenetic pathology of the Reln
promoter is operative in the transcriptional down-regulation
of the corresponding gene in SZ or BP disorder patients
is supported by the evidence that there is an increased
level of SAM in the PFC of these patients (Guidotti et al.,
2007), and that hypermethylation of the RELN promoter
(Abdolmaleky et al., 2005; Grayson et al., 2005, 2006; Lintas
and Persico, 2010) is associated with the down-regulation of
the corresponding protein in the PFC of psychotic patients
(Guidotti et al., 2000), although negative findings for RELN
promoter hypermethylation have also been reported (Mill et al.,
2008).
In other studies a decreased histone methylation at
GABAergic gene promoters (Huang et al., 2007), and an
increased histone deacetylase -1 expression and down regulation
of GABAergic gene expression in PFC and hippocampus of
SZ patients have been reported (Benes et al., 2007; Sharma
et al., 2008). A summary of many of the methylation studies
of RELN in neuropsychiatric patients, SZ-like epigenetic
mouse models, and neuronal culture systems are summarized
in Table 1. These data are consistent with the epigenetic
GABAergic theory of major psychosis (Costa et al., 2003;
Grayson and Guidotti, 2013) and suggest that RELN promoter
methylation should be further studied to establish its temporal
and casual association with the etiopathogenesis of SZ and BP
disorder.
RELN, SPINE DENSITY DOWN
REGULATION AND COGNITIVE
PERFORMANCE DEFICITS INDUCED BY
L-METHIONINE TREATMENT
Support for the hypothesis that an increase of DNA methylation
contributes to the down-regulation of RELN and other
GABAergic or glutamatergic genes in psychotic patients is
sustained by clinical studies conducted in the early 1970s
(for review see Wyatt et al., 1971; Cohen et al., 1974;
Grayson et al., 2009). In these studies L-methionine (MET, the
precursor of SAM), administered in large doses (10–20 g/day)
FIGURE 3 | Photomicrographs of Golgi stained layer III pyramidal
neurons in vehicle (VEH) and methionine (MET) treated mouse frontal
cortex. Top panel: 10× objective; Middle panel: 20×; Bottom panel: 100×
Vehicle or L-methionine (5.2 mmol/kg/twice a day) was administered for 14
days. Reprinted with permission from Tueting et al. (2010).
for 3–4 weeks to SZ patients was reported to exacerbate
psychotic symptomatology (Cohen et al., 1974; Grayson
et al., 2009). Patients were administered large doses of L-
methionine either with or without a monoamine oxidase
inhibitor in an attempt to reduce the levels of putative bioactive
psychedelic compounds. Interestingly, many of the treated
patients responded with a worsening of their symptoms (Cohen
et al., 1974).
In both mouse FC and neuronal cultures, the administration
of large doses of L-methionine increases SAM levels and
facilitates the hypermethylation of GABAergic gene promoters,
including Reln, and GAD67 and the reduced expression of
these genes (Tremolizzo et al., 2002, 2005; Mitchell et al.,
2005; Noh et al., 2005; Chen et al., 2007). Similar to the
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HRM, spine density is also decreased in the dendrites of
mice treated with L-methionine (Figure 3, Tueting et al.,
2010). Furthermore, L-methionine treated mice display SZ-like
behavioral abnormalities (Tremolizzo et al., 2005). Collectively,
these data suggest that the reduction of dendritic spines
observed in brain of L-methionine-treated mice are likely due
to MET-induced altered epigenetic mechanisms that lead to
decreased expression of RELN (Tremolizzo et al., 2005; Tueting
et al., 2010).
RELN PROMOTER METHYLATION IN
NEURONS IS A DYNAMIC PROCESS THAT
CAN BE TARGETED BY ENVIRONMENTAL
FACTORS AND DRUGS
The dogma that in post-mitotic neurons DNA methylation
patterns are established during development and remain stable
thereafter (Razin and Shemer, 1995) has been challenged
by convincing evidence that in post-mitotic neurons,
methylation patterns of specific cytosine/guanine (CpG)
dinucleotide-rich promoters, change rapidly. Thus, in neurons,
promoter methylation provides a series of targets on which the
environment, drugs, and/or toxins can modify transcription
and affect neuronal phenotype profiles without altering the
genotype (Szyf, 2009). To verify this hypothesis, we treated
(Tremolizzo et al., 2002, 2005; Tueting et al., 2010) mice
protractedly with L-methionine (as described above) and
measured the ratio of 5 methyl cytosine (5mC) to unmethylated
cytosine (C) of the murine RELN CpG-enriched promoter
region from −340 to +160 bp (Tremolizzo et al., 2005) or
the murine GAD67 CpG-enriched promoter region from
−760 to −311 bp (Satta et al., 2008) by measuring the
fraction of promoters immunoprecipitated by specific anti-
5mC or anti-MeCP2 antibodies with competitive RT-PCR
and internal standards (Dong et al., 2005). We found that
(Dong et al., 2005; Tremolizzo et al., 2005) methionine
induces an increase of brain RELN and GAD67 promoter
methylation (Dong et al., 2005), and downregulation of
RELN and GAD67 mRNA and cognate protein expression
associated with decreased spine density (Figure 3), and
SZ-like behavioral modifications (Tremolizzo et al., 2002,
2005; Tueting et al., 2010). The effects of methionine on the
RELN promoter, RELN protein level, dendritic spine density,
and SZ-like behavioral modifications are reversed by the
administration of Valproic acid (VPA) and other HDAC
inhibitors (Dong et al., 2005; Tremolizzo et al., 2005). These
findings, together with data obtained in the HRM, suggest
the working hypothesis that the down-regulation of spine
density and SZ-like behavioral modifications in L-methionine
treated mice may be, in part, due to decreased expression of
RELN.
CONCLUDING REMARKS
SZ and BP are neurodevelopmental disorders with genetic risk
load and behavioral and neurochemical SZ-like phenotypes
triggered by exposure to prenatal or perinatal environmental
insults: stress, toxins, infection, trauma. In mice exposed
prenatally to restraint stress, we found increased DNMT levels
that are associated with RELN promoter hypermethylation,
RELN expression downregulation, SZ-like epigenetic behavioral
modifications, and decreased dendritic spine density in
adultood (Tremolizzo et al., 2005; Tueting et al., 2010;
Dong et al., 2016). L-Methionine supplementation in rats
induces epigenetic variations including RELN promoter
hypermethylation in offspring (Weaver et al., 2005).
Further, there is an epigenomic reprogramming of RELN
and glucocorticoid receptors in hippocampal pyramidal
neurons after methionine administration (Weaver et al.,
2006). Our studies in cultured mouse cortical neurons
(Noh et al., 2005) and human neuronal progenitors
(Kundakovic et al., 2007, 2009) not only show that the
hypermethylation of promoters induced by L-methionine
is blocked by siRNA-mediated DNMT-KO or by reduction
of DNMT activity with small molecule antagonists but
also that this blockade induces the overexpression of
RELN, GAD67, or BDNF proteins (Kundakovic et al., 2007,
2009).
Collectively, these data challenge the classic concept
that 5-methylcytosine patterns in DNA remain stable
in post-mitotic neurons and strongly suggest that by
increasing brain SAM content, L-methionine facilitates the
promoter methylation mediated by DNMT1 or DNMT3a
in the central nervous system (Grayson and Guidotti,
2013). Unlike the DNA sequence of a cell, which is
stable and strongly conserved, epigenetic processes that
impact DNA methylation and chromatin architecture
are highly dynamic. That is, they can be tissue-specific,
developmentally-regulated, and modified by a wide range
of drugs and other environmental factors (Szyf, 2009; Ptak
and Petronis, 2010; Grayson and Guidotti, 2013; Dong et al.,
2016).
Studies using the L-methionine mouse model or offspring
of restraint stressed mothers may be aimed at determining
whether antipsychotics capable of reducing RELN promoter
methylation (e.g., clozapine), enhance spine density, and relieve
SZ-like epigenetic behaviors (Tremolizzo et al., 2005; Dong
et al., 2016). These models should provide useful preclinical
tools for screening small molecules for their capacity to reverse
SZ candidate gene promoter methylation and the associated
neuronal and behavioral deficits.
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